US FDA approves Novartis drug to treat kidney disease
The US Food and Drug Administration has approved the use of a Novartis drug to reduce excess protein in the urine of patients with a type of kidney disease. The drug Fabhalta is already approved to treat adults with paroxysmal nocturnal haemoglobinuria, a rare blood disorder.
POPULAR POSTS
Poland prepares for peaking floods
September 20, 2024
Italy evacuates thousands as Boris hits the north
September 20, 2024
China and the US race to tame nuclear fusion for clean energy
September 20, 2024
LIVE STREAM